Vernay to showcase new Medical Flow Control Solutions at MD&M West 2019!

Vernay Laboratories is proudly participating in the MD&M West 2019 Exhibition. Vernay will feature a comprehensive line of Medical Flow Control Solutions, introduce the next generation of check valves - the Supravalve MAX and along with our partner Quantex, offer a new mobile app controlled Drug Delivery Platform: Quantex 4C.  The Global Medical Team will also conduct live product demonstrations.


Medical Design & Manufacturing West (MD&M) is the largest exhibition of medical technology in North America.  This 3 day event is being held from February 5-7, 2019 at the Anaheim Convention Center in Anaheim, California, USA. This event showcases medical industry products and the latest technologies, including: flow control and medicine dispersement solutions, 3D printing, new battery technology, and new materials developments.


Continuing to build on a long tradition of innovation, Vernay will introduce a next generation check valve - the Supravalve MAX which sets the new standard for maximum flow control performance.  Incorporating a unique normally closed duckbill valve design, the new Vernay Supravalve MAX provides maximum reverse leak protection at low opening pressure.  "As a Researcher, I am really excited to be able to introduce new technologies, which we are fortunate at Vernay to do often", states Bob Ferguson, VP of Vernay Global Research and Development.  He adds: " I specifically appreciate it when the technology represents significant innovative features.  The Vernay Normally Closed Duckbill Technology® is a radically innovative design, in the respect that typical duckbill valves are comparatively considered to be normally-open designs.  The significance of a normally closed duckbill represents the convergence of multiple performance benefits such as reduced tortuous flowpath in the forward direction while maintaining comparatively non-existent reverse direction leakage, even in the low pressure regions.  These benefits, combined into one "simple to connect" valve assembly (utilizing standard connections) will certainly provide our customers with a promising new solution for their fluid control challenges".


Vernay, in partnership with Quantex, will also feature a new wearable, mobile app controlled Drug Delivery Platform: Quantex 4C, which allows patients to self-infuse up to 100ml of medication during a 1 week time period.  Andy Woodward, Vernay Global Sales and Marketing VP believes “This new technology has tremendous potential because of its ability to deliver precise dispensing accuracy to patients, while allowing medical professionals access to monitor infusion data remotely through the app.”


The Vernay Medical Division has significant expertise in medical flow control applications including: Blood & System Management, Cardiopulmonary System Management, Diagnostic Imaging, Enteral Feeding, Respiratory System Management, Urology, Wound Care Management, and more.


Vernay is a worldwide flow control solutions provider and a leading developer of custom engineered solutions.  Founded in 1946, Vernay engineers and chemists are recognized throughout the industry for their tenacious problem solving capability.  Vernay’s global manufacturing reach and local co-development Engineering Centers support customers throughout the medical industry.


Vernay and London based Quantex have formed a strategic partnership to develop and bring single-use precision pumps to the Flow Control Market.


Come visit us at the Anaheim Convention Center at Booth 1958.  We are ready to listen and support you!



Vernay at MD&M:

Booth:     1958
Date:       February 5-7, 2019
Hours:     7am - 6pm
Address:  800 W Katella Ave, Anaheim, CA 92802, USA

Featured Products:

SupraValve MAX®

V-Flow® Dispenser Valves

Quantex 4C

Q-Pump Series Disposable Pumps


Best Regards,

The Vernay Global Marketing Team


To learn more about Vernay visit our website or contact us through email at